Marks Group Wealth Management, Inc Sanofi Transaction History

Marks Group Wealth Management, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	BUY	$47.07 - $52.35 $209,320 - $232,800	4,447 New	4,447 $208,000
Q3 2021 Nov 15, 2021	SELL	$47.89 - $53.12 $198,408 - $220,076	-4,143 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$49.36 - $54.25 $204,498 - $224,757	4,143 New	4,143 $218,000
Q1 2021 May 17, 2021	SELL	$45.46 - $50.51 $195,250 - $216,940	-4,295 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$42.91 - $52.5 $184,298 - $225,487	4,295 New	4,295 $219,000

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $120B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Marks Group Wealth Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Marks Group Wealth Management, Inc with notifications on news.